◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 6618

JD Health International Inc. (6618) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-08-10

JD Health International Inc. (6618) operates in the Pharmaceutical Retailers industry and is headquartered in Beijing, China with about 5,263 employees. Its market capitalization is roughly CNY 124 billion. In the fiscal year ended 2025-12-31, 6618 reported CNY 73.4B in revenue and CNY 5.4B in net income.

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China.

Interactive charts & full statements →

6618 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 73.4BCNY 58.2BCNY 53.5BCNY 46.7B
Gross ProfitCNY 18.2BCNY 13.3BCNY 11.9BCNY 9.9B
Operating Income (EBIT)CNY 3.9BCNY 1.5BCNY 701M(CNY 47M)
Net IncomeCNY 5.4BCNY 4.2BCNY 2.1BCNY 380M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6618 Free Cash Flow History

6618 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 81.6BCNY 71.3BCNY 64.3BCNY 61.3B
Total LiabilitiesCNY 21.5BCNY 16.0BCNY 14.9BCNY 16.5B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6618 viewer.

Other Companies in Pharmaceutical Retailers

← 6617All “0-9” companies6619 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.